Skip to main content

Table 2 Grade I/II and grade III/IV toxicity during 6 cycles of TAC in both groups

From: The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

 

Grade I/II

 

STF

Non-STF

Fatigue

5 (71 %)

6 (100 %)

Infection

3 (43 %)

1 (17 %)

Mucositis

4 (57 %)

4 (67 %)

Neuropathy

5 (71 %)

3 (50 %)

Diarrhea

5 (71 %)

2 (33 %)

Dizziness

3 (43 %)

3 (50 %)

Nausea

7 (100 %)

4 (67 %)

Eye complaints

4 (57 %)

2 (33 %)

Constipation

4 (57 %)

2 (33 %)

 

Grade III/IV

Total

6

3

Neutropenic fever

2 (29 %)

2 (33 %)

Fatigue

2 (29 %)

0 (0 %)

Infection

2 (29 %)

1 (17 %)

  1. All side effects were scored according CTCAE4.03. Each side effect was scored maximal once per patient during the course (the highest grade of occurrence was scored)
  2. STF short-term fasting